IP Library Granted Patent US 8,642,654
Granted Patent B2
US 8,642,654 · App. 13/031,006 · Granted Feb 4, 2014

Hydroxybutyrate ester and medical use thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,642,654
App. No.
13/031,006
Granted
Feb 4, 2014
Kind
B2
Abstract

A compound which is 3-hydroxybutyl 3-hydroxybutyrate enantiomerically enriched with respect to (3R)-hydroxybutyl (3R)-hydroxybutyrate of formula (I) is an effective and palatable precursor to the ketone body (3R)-hydroxybutyrate and may therefore be used to treat a condition which is caused by, exacerbated by or associated with elevated plasma levels of free fatty acids in a human or animal subject, for instance a condition where weight loss or weight gain is implicated, or to promote alertness or improve cognitive function, or to treat, prevent or reduce the effects of neurodegeneration, free radical toxicity, hypoxic conditions or hyperglycaemia.

Claims (6)

1. An ingestible composition comprising a compound which is 3-hydroxybutyl 3-hydroxybutyrate enantiomerically enriched with respect to (3R)-hydroxybutyl (3R)-hydroxybutyrate of formula (I):

and a dietetically or pharmaceutically acceptable carrier.

2. A composition according to claim 1 which is a food product, a beverage, a drink, a food supplement, a dietary supplement, a functional food, a nutraceutical or a medicament.

3. A method of treating a condition which is caused by, exacerbated by or associated with elevated plasma levels of free fatty acids in a human or animal subject, which method comprises administering to the subject a composition as defined in claim 1 .

4. A method of suppressing appetite, treating obesity, promoting weight loss, maintaining a healthy weight or decreasing the ratio of fat to lean muscle, which method comprises administering to a subject in need thereof a composition as defined in claim 1 .

5. A method of treating a condition selected from muscle impairment and muscle fatigue, which method comprises administering to a subject in need thereof a composition as defined in claim 1 .

Assignments (3)
CHANGE OF NAME Recorded Aug 2, 2016
From: ISIS INNOVATION LIMITED
To: OXFORD UNIVERSITY INNOVATION LIMITED
Reel/Frame 039550/0045 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 14, 2011
From: CLARKE, KIERAN
To: ISIS LNNOVATION LIMITED
Reel/Frame 026905/0273 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 14, 2011
From: VEECH, RICHARD LEWIS
To: GOVERNMENT OF THE USA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
Reel/Frame 026905/0304 →